RH: Analysis & Opinions

  1. Thermo Steps Up And Seals A Deal For Life Technologies

    April 19, 2013
    Speculation has been all over the place for an M&A with LifeTech, but the final announcement is consistent with my ...
  2. Pharma Is Doing All The Pulling For Johnson & Johnson

    April 17, 2013
    Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
  3. Red Hat's Valuation Looks More Reasonable, But ...

    March 28, 2013
    While Red Hat's model doesn't generate much leverage, the revenue growth is still looking solid.
  4. The Lodging Sector Finally Rebounds

    March 27, 2013
    After being commercial real estate’s whipping boy since the Great Recession, the lodging sector is finally beginning ...
  5. Roche Collaborates with RQx Pharma - Analyst Blog

    February 13, 2013
    Roche (RHHBY) recently entered into a drug discovery collaboration with privately-held RQx Pharmaceuticals, Inc. ...
  6. Wyndham's RCI on an Expansion Mode - Analyst Blog

    February 11, 2013
    Wyndham Worldwide Corporation's (WYN) leading vacation exchange network, RCI, recently declared the inclusion of 150 ...
  7. Affymetrix Links Up with DNA Link - Analyst Blog

    February 11, 2013
    Genetic products company, Affymetrix Inc. (AFFX), inked a 'Powered by Affymetrix' ("PbA") Program agreement with ...
  8. Montpelier Re Betters Estimate - Analyst Blog

    February 08, 2013
    Montpelier Re Holdings Ltd. (MRH) reported fourth quarter 2012 operating loss of 31 cents per share, better than the ...
  9. Loss Widens at Alnylam, Sales Fall - Analyst Blog

    February 08, 2013
    Alnylam Pharmaceuticals Inc.'s (ALNY) fourth quarter 2012 loss of $1.20 per share was narrower than the Zacks ...
  10. Prologis Reports In Line, Rev Up - Analyst Blog

    February 06, 2013
    Prologis Inc.'s (PLD) core FFO (funds from operations) per share of 42 cents were in line with the Zacks Consensus ...
  11. QCRH: Fourth Quarter EPS Up 40% and Above Our Estimate ...

    February 06, 2013
    QCRH: Fourth Quarter EPS Up 40% and Above Our Estimate  By Ann Heffron, CFA QCR Holdings, Inc. (NasdaqGM:QCRH) ...
  12. Manpower Reiterated at Neutral - Analyst Blog

    February 04, 2013
    We reaffirm our long-term Neutral recommendation on ManpowerGroup (MAN), the global leader in the employment ...
  13. Roche Grows in 2012 - Analyst Blog

    February 01, 2013
    Roche Holdings Ltd. (RHHBY) recently reported 2012 results. Revenues grew 4% year over year to CHF 45.5 billion ...
  14. Merck Beats, Issues Outlook - Analyst Blog

    February 01, 2013
    Merck & Co. (MRK) reported fourth quarter 2012 earnings per share (excluding special items) of 83 cents, a couple of ...
  15. Pipeline Progress at Endocyte - Analyst Blog

    January 31, 2013
    Endocyte Inc. (ECYT) recently announced that its oncology candidate, EC0652, achieved key objectives in a phase 0 ...
  16. Roche Teams Up With Afraxis - Analyst Blog

    January 30, 2013
    Roche (RHHBY) announced that its wholly owned subsidiary, Genentech, has recently inked a global licensing agreement ...
  17. Robert Half Beats by a Penny in 4Q - Analyst Blog

    January 30, 2013
    Leading staffing firm Robert Half International Inc. (RHI) reported fourth quarter 2012 earnings of 42 cents, ...
  18. Summit Hotel Expands in Louisiana - Analyst Blog

    January 29, 2013
    In order to expand its footprints in La., Summit Hotel Properties, Inc. (INN) recently penned a deal with Marriott ...
  19. Generic Launch at Dr. Reddy's - Analyst Blog

    January 28, 2013
    Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of Merck & Co's (MRK) Singulair ...
  20. Wider Loss at ImmunoGen - Analyst Blog

    January 28, 2013
    ImmunoGen Inc. (IMGN) reported second quarter fiscal 2013 adjusted loss of 29 cents per share, wider than both the ...
Marketplace
Trading Center